Events & Training for February 2020
Parallel Trade 2020
04 February 2020 - 05 February 2020
SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London on the 4th-5th of February 2020. As the only B2B parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.
The size of the EU market in pharmaceutical distribution is around €5bn, and the UK accounts for 22.7% of this figure. The sector has an annual import value of around £1bn, while the annual export figure approximates £600m.
The 2020 event will hold a particular place of significance on shortages of medicines, current and ongoing challenges posed by Parallel Trading, potential implications of Brexit and IP exhaustion rights.
Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2020. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.
Holiday Inn Kensington Forum, London, UK
http://www.parallel-trade.com/DDTwl
Expanding the Druggable Proteome with Chemical Biology
05 February 2020 - 07 February 2020
Despite the exciting advances in human genetics over the past decade, the fraction of the human proteome targeted by small molecules remains relatively small compared to the total number of genes linked to a disease phenotype by Mendelian inheritance or genome-wide association studies. Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology with three major themes:
illuminating the druggable genome
chemical interrogation of the druggable proteome
new engineering approaches for breaking the druggability barrier
EMBL Heidelberg, Germany
https://www.embl.de/training/events/2020/CPP20-01/index.html?utm_source=drugdiscoverytoday&utm_medium=referral&utm_campaign=CPP20-01
The antibody revolution by Sir Gregory Winter: The 2020 Jephcott Lecture
05 February 2020
Molecular biologist and Nobel Prize winner Sir Gregory Winter will give this year’s Jephcott Lecture at the RSM. Exploring the theme ‘The antibody revolution’ Sir Gregory will describe how in recent years antibodies have emerged as a new class of pharmaceutical drugs. Many of the best-selling and most expensive pharmaceutical drugs are now antibodies, particularly for treatment of auto-immune inflammatory conditions such as rheumatoid arthritis and cancer. He will go onto discuss how continuing technology development is opening up new prospects for treatment of disease by antibodies and by small antibody mimics.
Royal Society of Medicine 1 Wimpole Street, London, W1G 0AE
https://www.rsm.ac.uk/events/public-engagement/2019-20/pen07/
RNA Therapeutics
19 February 2020 - 20 February 2020
The RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene and protein expression, and genome editing.
Copthorne Tara Hotel, London, UK
http://www.therapeutics-rna.com/DDT
SMi’s 4th Annual 3D Cell Culture
19 February 2020 - 20 February 2020
Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.
At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.
Join us at SMi’s 9th Annual Pharmaceutical Microbiology Conference to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.
#SMiPharmaMicroUK
Copthorne Tara Hotel, London, UK
http://www.3d-cellculture.com/ddtl